Ken Griffin's position in Viridian Therapeutics is currently worth $12.1M. That's 0.01% of their equity portfolio (1220th largest holding). The first Viridian Therapeutics trade was made in Q1 2021. Since then Ken Griffin bought shares eight more times and sold shares on eight occasions. The stake costed the investor $10.9M, netting the investor a gain of 11% so far.